Company: AEMD
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001683168-25-008271
Chunk: 78

Company: AETHLON MEDICAL INC
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 2
Chunk 78
---
 attributable to common
stockholders was ($3.74) for the three months ended September 30, 2025, compared to ($16.11) for the three-month period ended September
30, 2024.

SIX MONTHS ENDED SEPTEMBER 30, 2025 COMPARED TO THE SIX MONTHS ENDED
SEPTEMBER 30, 2024

Operating Expenses

Consolidated operating expenses for the six months
ended September 30, 2025 were approximately $3,302,000, compared to approximately $5,522,000 for the six months ended September 30, 2025.
This decrease of approximately $2,220,000, or 40%, in the 2025 period was due to decreases in payroll and related expenses of approximately
$1,452,000, general and administrative expenses of $453,000 and professional fees of $315,000.

The $1,452,000 decrease in payroll and related
expenses was primarily due to an $826,000 charge in the prior period related to severance agreements and workforce reductions, a $516,000
decrease from lower headcount and related compensation, and a $108,000 reduction in stock-based compensation associated with the reduced
headcount. 

 20 

General and administrative expenses decreased
approximately $453,000 for the six months ended September 30, 2025, primarily due to the recognition of a $218,000 R&D tax incentive
for Australian R&D related to the trial, lower insurance costs of $66,000 from reduced headcount, and a $71,000 decrease in supplies.
Additional decreases of $14,000 in utilities, $8,000 in business-related taxes, $13,000 in computer software, and $28,000 across various
other categories contributed to the overall change. These decreases were partially offset by an approximate $33,000 rent charge for a
lost deposit.

Professional fees decreased approximately $315,000,
primarily due to lower investor relations of approximately $222,000, reduced general and SEC legal fees of approximately $119,000, and
a combined $72,000 decrease in scientific consulting, contract labor, and audit and accounting services, partially offset by $94,000 in
patent legal fees related to new filings, maintenance, and associated costs.

Net Loss

As a result of the changes in expenses noted above,
our comprehensive loss decreased from $5,375,443 in